Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Stomasense: En ny rute til den proaktive detektion og styring af lækager inden for stomiposer

10. november 2026 opdateret af: University of Ulster

People living with an ileostomy may often experience leaks from their stoma pouches. Leakages are a highly stressful experience, so it is no surprise that worry about leaks is very common among ileostomates and this can contribute to increased anxiety and impact negatively on quality of life. Ileostomates will make changes to their lifestyle to minimise the occurrence of leaks; they may avoid travelling long distances, steer clear of busy social events and often restrict certain food(s) and / or drink(s). The latter stands in the way of achieving a healthy balanced diet and can put ileostomates at risk of developing nutritional deficiencies.

Researchers at ulster university have developed a leak sensor device which can be worn unobtrusively alongside any stoma pouch. The device can detect the early stages of a leak from the stoma bag and alerts the user, meaning they are able to change their pouch before it's too late. Participants will be asked to trial 2 versions of the device, each over a 2-week period. At the beginning and end of each period participants will complete a series of questionnaires to allow the research team to determine device efficacy and impact on quality of life. Food diaries will also be completed by participants to give an indication of how dietary intake can impact the incidence of pouch leakage.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Surgical diversion of the bowel to create an opening in the abdomen (stoma) is a common procedure in the treatment of various gastrointestinal conditions; 21 000 stomas are created in the UK each year and it is estimated that 176 000 - 205 000 individuals in the UK are living with a stoma. This is a life-changing operation which requires significant physical and psychological adaptation particularly as bowel/bladder content is collected in a disposable pouch that adheres to the abdomen. Leakage, especially in public, is a constant worry resulting in decreased social interactions, increased anxiety and depression and can have a tremendous impact on family and work life. The extent of the problem was confirmed by the Ostomy Life Study (2015) which surveyed some 4000 ostomates from 11 different countries and found the majority (91%) of participants reported that leakage of the pouch was a concern with 69% confirming that it was their prime worry and greatly impacted on their quality of life (QoL). Leakage events are very traumatic emotionally and will impact an individual's practical management of their ostomy; stoma effluent in contact with the epidermal layer is a major contributing factor in the development of peristomal skin complications (PCS), this in turn can cause difficulty in adhesion of the baseplate to the affected skin, therefore further contributing to the future leaks.

To put an end to this cycle of worsening skin integrity and subsequent increased frequency of leaks, new leak sensor technology has been developed by Ulster University which can be used with any stoma pouch system to detect the early onset of stoma pouch failure - providing an alert that allows the patient to replace the pouch before catastrophic seepage of bowel/bladder content.

Whilst this new leak sensor technology will be extremely useful in the early detection of leaks, it is important to also consider how an individual's management of their stoma, as well as health and lifestyle behaviours, could be manipulated to further reduce the incidence of leaks and improve QoL. In a previous study, participants identified food consumption (i.e., eating certain foods) as being the most prominent contributor to the incidence of leaks. It has been reported that fruit and vegetables are avoided by ostomates - in particular those with an ileostomy - to help minimise the risk of leaks. Obviously, this is less than ideal, considering the well-established health benefits of consuming a diet rich in fruit and vegetables. At present, there is no evidence confirming the efficacy of restricting dietary intake to reduce the frequency of leaks. Therefore, it is possible that people living with a stoma are unnecessarily restricting their dietary intake and putting themselves at risk of various nutrient deficiencies and associated health conditions.

The over-riding aim of the current proposal is to validate a smart device that can be worn unobtrusively alongside existing stoma pouch systems whilst monitoring the condition of the adhesive skin wafer, such that erosion of the bond can be detected before a leak occurs. This would enable the wearer to replace the pouch avoiding the consequences of leakage and accompanying distress, therefore improving QoL and psychological well-being. The impact of the device on participant well-being will be assessed using a series of validated questionnaires. The sensor is not a medical device as it only interacts with the stoma bag and flange and does not interact directly with the participant or their bodily fluids.

The sensing device will:

  1. Accurately detect the onset of leaks.
  2. Provide a discrete personal alert (vibration).
  3. Allow for wireless connectivity for those requiring carer / nursing support.
  4. Allow for differences in patient dexterity; two distinct probe systems (microbutton or microwire sensor) will be validated.

Therefore, this study seeks to test the sensor technology with ileostomates in a cross over study involving microbutton and microwire sensors. This study hopes to achieve an 85% success rate in the accurate detection of leaks.

The secondary aim of this study is to determine associations between dietary intake and the incidence of leakages. This information will have the potential to inform the development of dietary guidelines for those living with a stoma, and to therefore improve overall nutritional status and health of this patient group.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

50

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Co. Derry
      • Coleraine, Co. Derry, Det Forenede Kongerige, BT521SA
        • Ulster University, Human Intervention Studies Unit

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Living with an ileostomy
  • ≥1.5-years post-operative
  • Aged 18+ years
  • Experiencing frequent leaks (i.e., more than once per week)
  • Males and females (not currently pregnant/lactating)
  • Self-manging their own stoma
  • Access to computer / mobile device for survey completion
  • No learning or other disabilities
  • Have never used / trialled other leak detection systems

Exclusion Criteria:

  • Never had an ileostomy,
  • Individuals with previous ileostomy or ostomy (colostomy or urostomy)
  • <1.5-year post-operative
  • <18 years
  • Do not experience frequent leaks (i.e., less than once per week)
  • Adults with learning or other disabilities
  • Have previously used other leak detection systems
  • Pregnant/lactating female

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Crossover opgave
  • Maskning: Tredobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Leak detection device (microbutton probes)

Leakage events will be detected by microbutton probes, which are attached to the sensing device

A smart device worn alongside stoma pouch systems which detects onset of a leak.

Eksperimentel: Leak detection device (microwire probes)

Leakage events will be detected by microwire probes, which are attached to the sensing device

A smart device worn alongside stoma pouch systems which detects onset of a leak.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Psychiatric morbidity
Tidsramme: Comparison between treatments over a 2-week period.

Psychiatric morbidity will be assessed at the beginning and end of each test period using the General Health Questionnaire (GHQ-12).

Comparison between treatments over a 2-week period.
Psychological well-being
Tidsramme: Comparison between treatments over a 2-week period.

Psychological well-being will be assessed at the beginning and end of each test period using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

Comparison between treatments over a 2-week period.
General quality of life
Tidsramme: Comparison between treatments over a 2-week period.

General quality of life will be assessed at the beginning and end of each test period using the European Organization for Research and Treatment of Cancer (EORTC) QoL questionnaire for colorectal cancer (EORTCQLQ-CR38).

Comparison between treatments over a 2-week period.
General quality of life
Tidsramme: Comparison between treatments over a 2-week period.

General quality of life will be assessed at the beginning and end of each test period using the The World Health Organization Quality of Life - BREF (WHOQOL-BREF).

Comparison between treatments over a 2-week period.
Stress and coping
Tidsramme: Change over 2 weeks comparison between treatments

Stress and coping will be assessed at the beginning and end of each test period using the Perceived Stress Scale (PSS), which is a global measure of stress

Change over 2 weeks comparison between treatments
Resillience
Tidsramme: Change over 2 weeks comparison between treatments

Resillience will be assessed at the beginning and end of each test period using the Connor-Davidson Resilience Scale (CD-RISC)

Change over 2 weeks comparison between treatments
Stoma related quality of life
Tidsramme: Comparison between treatments over a 2-week period.

Stoma related quality of life will be assessed at the beginning and end of each test period using the Stoma QoL: A Quality-of-Life Questionnaire for People with an Ostomy

Comparison between treatments over a 2-week period.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Device accuracy
Tidsramme: Measured over 2 weeks comparison between treatments

Participants will keep a daily leak diary in which the incidence of leaks will be recorded. Participants will log leakage events as true positive (TP; successful detection of leak), false positive (FP; sensor alert but no leak occurred) or false negative (FN; occurrence of leak but no alert from device).

Measured over 2 weeks comparison between treatments
Device usability
Tidsramme: Measured at 2 weeks comparison between treatments

Participants will complete a user experience survey at the end of each treatment period.

Measured at 2 weeks comparison between treatments
Dietary intake
Tidsramme: Measured over 2 weeks comparison between treatments

Participants will complete 4-day food diaries at the beginning and end of each treatment period.

Measured over 2 weeks comparison between treatments
Peristomal skin condition
Tidsramme: Comparison between treatments over a 2-week period.

Participants will complete a short questionnaire which evaluates peristomal skin condition at the beginning and end of each treatment period.

Comparison between treatments over a 2-week period.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

30. april 2025

Primær færdiggørelse (Faktiske)

3. januar 2026

Studieafslutning (Faktiske)

3. januar 2026

Datoer for studieregistrering

Først indsendt

26. marts 2025

Først indsendt, der opfyldte QC-kriterier

2. april 2025

Først opslået (Faktiske)

6. april 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

12. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

10. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • UUREC/24/0074
  • MR W029561 (Andet bevillings-/finansieringsnummer: Medical Research Council)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .